Arkolith/Insider Trading/SKYE/Form 4

Grayson Paul A.

DirectorSkye Bioscience, Inc. (SKYE) · full profile →Form 4 · filed Nov 19, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$432K
Net Open-Market Flow
-$432K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2024Sell(S)86K$4.99$430K260K
Nov 15, 2024Sell(S)307$5.55$2K346K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001516551-24-000114) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML